The US Food and Drug Administration (FDA) has cleared Roche's Accu-Chek Combo system for insulin pump therapy. The Accu-Chek Combo system seamlessly combines a blood glucose meter with an insulin pump, which are able to exchange data in both directions via Bluetooth wireless technology.

The meter not only enables the user to quickly test blood glucose levels: It allows for operating the insulin pump remotely and by means of an easy-to-handle bolus advisor it provides support in defining the right amount of insulin. With this the Accu-Chek Combo system not only supports a more targeted therapy management, but it also allows for a discrete insulin administration without the need to touch the pump.

“We are very pleased to announce that our new insulin pump system will soon be available for people with diabetes in the US,” said Daniel O’ Day, COO Roche Diagnostics. “With this clearance we are now looking forward to launch the second device in the US this year, after the successful clearance of the Accu-Chek Nano SmartView system in the first quarter. Both launches represent a significant milestone for our Diabetes Care business.”

“The Accu-Chek Combo system clearly demonstrates Roche’s dedication to integrated diabetes management solutions, combining the technical components for blood glucose monitoring, data management and insulin delivery. This new system is designed to support insulin pump patients in managing diabetes easily and discretely in their everyday life,” said Luc Vierstraete, Head of Roche Diabetes Care.

The Accu-Chek Combo system has been launched successfully in several European and APAC(Asia-Pacific) countries already - including France, Germany, UK, and Australia.

In addition to being discrete and easy-to-use, the Accu-Chek Combo system also features:

Bluetooth technology for two-way wireless communication between the smart meter and the insulin pump.

A full-colour display that brings to life blood glucose data, insulin dose information and pump settings.

A bolus advice function on the meter to allow users to easily calculate and deliver a bolus without touching the pump.

Flexibility to adjust the basal rate to as low as 0.05 units per hour – in increments as precise as 0.01 units.

An insulin cartridge that holds up to 315 units of insulin, the largest capacity among pumps sold in the US.

Roche Diabetes Care is a pioneer in the development of blood glucose monitoring systems and a global leader for diabetes management systems and services.

Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS.